Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Breast Cancer Research and Treatment|May 22, 2010
A gene expression signature identifies two prognostic subgroups of basal breast cancerRenaud Sabatier, Pascal Finetti, Nathalie Cervera, et al.Cancer Research|May 3, 2006
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancersFrançois Bertucci, Pascal Finetti, Nathalie Cervera, et al.JCI Insight|June 14, 2019
Sensitive and easy screening for circulating tumor cells by flow cytometryAlexia Lopresti, Fabrice Malergue, François Bertucci, et al.Oncotarget|September 3, 2016
Prognostic value of PDL1 expression in pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.Cancer Genomics & Proteomics|April 24, 2016
Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic AdenocarcinomaDavid J Birnbaum, François Bertucci, Pascal Finetti, et al.Journal of Translational Medicine|December 5, 2025
The plasma nanoDSF denaturation profiles predict the presence of breast cancerMathilde Guerin, Rémi Eyraud, Philippe Tsvetkov, et al.Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.Oncoimmunology|June 9, 2021
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitorsFrançois Bertucci, Laurys Boudin, Pascal Finetti, et al.Frontiers in Oncology|August 15, 2022
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trialRenaud Sabatier, Séverine Garnier, Arnaud Guille, et al.Molecular Oncology|June 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterizationAlexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, et al.Pageof 9